ANTIHYPERTENSION STUDY OF ANREDERA CORDIFOLIA (TEN). V. STEENIS EXTRACT AND ITS FRACTIONS IN RATS THROUGH DEXAMETHASONE INDUCTION AND NITRIC OXIDE RELEASE.
Â Objective: The aims of this study were to prove the antihypertensive effect of Anredera cordifolia (Madeira vine) in dexamethasone-induced hypertensive rat and to determine the release of nitric oxide (NO).
Methods: The ratâ€™s blood pressure was measured by CODAÂ® tail-cuff blood pressure system. A hypertensive rat model was developed on day 7 after administration of dexamethasone injection 0.5 mg/kg body weight (bw). NO levels were measured by spectrophotometry at a wavelength of 546 nm after reacting the serum sample with Griess reagent.
Results: Ethanol extract of Madeira vine (EEMV), ethyl acetate fraction (EF), and water fraction (WF) could reduce systolic blood pressure at day 14 with a diastolic blood pressure (DBP) reduction of 26.8, 34.1, and 40.5 mmHg, respectively. DBP began to decrease from day 8 in the EEMV group with a DBP reduction of 24.1 mmHg. In the HF, EF, and WF groups, decreasing in DBP occurred on day 14 which were 22.0, 24.5, and 35.4 mmHg, respectively. NO level in rat serum was increased significantly at 90 min after administration of EEMV 100 mg/kg bw and WF 40.73 mg/kg bw. Increasing in NO levels due to EF with a dose of 1.66 mg/kg bw was not significantly different to control group.
Conclusion: Ethanol extract of A. cordifolia had the antihypertensive effect in dexamethasone-induced hypertensive rats, so does its WF and EF. The mechanism of ethanol extract of Madeira vine leaves and its WF most likely due to vasodilation effect through NO-pathway, whereas EF could have other mechanism(s) of action.
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States. Circulation 2011;123(8):933-44.
3. Brunton LL, Chabner BA, Knollmann MB, editors. Goodman and Gilmanâ€™s the Pharmacological Basis of Therapeutics. 12th ed. New York: The McGraw-Hill Companies, Inc.; 2011.
4. Saseen JJ, MacLaughlin EJ. Hypertension. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: A Pathophysiologic Approach. 9th ed. New York: McGraw-Hill Education; 2014. p. 156-203.
5. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003;52:1361-71.
6. Singh P, Mishra A, Singh P, Goswami S, Singh A, Tiwari KD. Hypertension and herbal plant for its treatment: A review. Indian J Res Pharm Biotechnol 2015;3(5):358-66.
7. Garmana AN, Sukandar EY, Fidrianny I. Preliminary study of blood pressure lowering effect of Anredera cordifolia (Ten.) steenis) on Wistar rats. Int J Pharmacogn Phytochem Res 2016;8(2):300-4.
8. Sukandar EY, Ridwan A, Sukmawan YP. Vasodilatation effect of ethanolic extract of Anredera cordifolia, Sonchus arvensis L, and ursolic acid on isolated rabbit aortic and frog heart. Int J Pharm Pharm Sci 2016;8(2):145-9.
9. Kaaffah S, Kurniwati F, Kusuma AM, Djalil AD. The effect of ethanol extract from binahong leaves (Anredera cordifolia (Ten.) steenis) on histopathology changes in female Wistar rats. In: Proceeding of The 1st University of Muhammadiyah Purwokerto-Pharmacy International Conference; 2015. p. 18-26.
10. Salasanti CD, Sukandar EY, Fidrianny I. Acute and sub chronic toxicity study of ethanol extract of Anredera cordifolia (Ten.) v. steenis leaves. Int J Pharm Pharm Sci 2014;6(5):348-52.
11. Sukandar EY, Kurniati NF, Fitria V. Evaluation of teratogenicity effects of ethanolic extracts of binahong leaves (Anredera cordifolia (Ten) steenis) in Wistar rat. Int J Pharm Pharm Sci 2014;6(11):422-6.
12. Ong SL, Zhang Y, Whitworth JA. Mechanisms of dexamethasone-induced hypertension. Curr Hypertens Rev 2009;5:61-74.
13. Nagata K, Murohara T, Miyachui M, Ohtake M, Tsuboi K, Ohtake M, et al. Glucocorticoid-induced hypertension and cardiac injury: Effects on mineralocorticoid and glucocorticoid receptor antagonism. Nagoya J Med Sci 2013;75:81-92.
14. Safaeian L, Zabolian H. Antioxidant effects of bovine lactoferrin on dexamethasone-induced hypertension in rat. ISRN Pharmacology 2014;1-6.
15. Wallwork CJ, Parks DA, Schmid-SchÃ¶nbein GW. Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 2003;66(1):30-7.
16. Handa M, Kondo K, Suzuki H, Saruta T. Dexamethasone hypertension in rats: Role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension 1984;6:236-41.
17. Ozdestan O, Uren A. Development of a cost-effective method for nitrate and nitrite determination in leafy plants and nitrate and nitrite contents of some green leafy vegetables grown in the Aegean region of Turkey. J Agric Food Chem 2010(9);58(9):5235-40.
18. Amalia L, Sukandar EY, Roesli R, Sigit JI. The effect of ethanol extract of kucai (Allium schoenoprasum L.) bulbs on serum nitric oxide level in male wistar rats. Int J Pharm 2008;4:487-91.
19. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolitesin biological samples. Free Radic Biol Med 2007;43(5):645-57.
20. Martini FH, Nath JL, Bartholomew EF. Fundamentals of Anatomy and Physiology. 10th ed. San Francisco: Pearson Education, Inc.; 2015.
21. Pandey VG, Jain S, Rana A, Puri N, Arudra SK, Mopidevi B, et al. Dexamethasone promotes hypertension by allele-specific regulation of the human angiotensinogen gene. J Biol Chem 2015;290:5749-58.
22. Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertension Res 1996;19(1):1-8.
23. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991;88(2):385-9.
24. Haigh RM, Jones CT. Effect of glucocorticoids on alpha 1-adrenergic receptor binding in rat vascular smooth muscle. J Mol Endocrinol 1990;5(1):41-8.
25. Zhou MS, Jaimes EA, Raij L. Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens 2004;17:167-71.
26. Adnyana IK, Setiawan F, Insanu M. From ethnopharmacology to clinical study of orthosiphon stamineus benth. Int J Pharm Pharm Sci 2013;5(3):66-73.
27. Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci 2015;129:83-94.
28. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156-67.
29. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999;1411:273-89.
30. Sharifi N, Souri E, Ziai SA, Amin G, Amanlou M. Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay. DARU J 2013;21(71):1-8.
31. Babbar N, Oberoi HS, Sandhu SK, Bhargav VK. Influence of different solvents in extraction of phenolic compounds from vegetable residues and their evaluation as natural sources of antioxidants. J Food Sci Technol 2014;51(10):2568-75.
32. Balasuriya BN, Rupasinghe HV. Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Funct Foods Health Dis 2011;1(5):172-88.
33. Croft KD. The chemistry and biological effects of flavonoids and phenolic acids. Ann N Y Acad Sci 1998;854:435-42.
34. Stevenson DE, Hurst RD. Polyphenolic phytochemicals-just antioxidants or much more? Cell Mol Life Sci 2007;64(22):2900-16.
35. Mladenka P, ZatloukalovÃ¡ L, FilipskÃ½ T, Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med 2010;49(6):963-75.
36. Duarte J, Francisco V, Perez-Vizcaino F. Modulation of nitric oxide by flavonoids. Food Funct 2014;5:1653-68.
37. Sudano I, Flammer AJ, Roas S, Enseleit F, Ruschitzka F, Corti R, et al. Cocoa, blood pressure, and vascular function. Curr Hypertens Rep 2012;14(4):279-84.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.